Report cover image

Gene Editing Market Size , Industry, Share, Analysis, Trends and Global Forecast 2025 - 2033

Publisher Acumen Research and Consulting
Published Mar 01, 2025
Length 250 Pages
SKU # ACRC19838265

Description

The Global Gene Editing Market Size accounted for USD 18.3 Billion in 2024 and is estimated to achieve a market size of USD 73.7 Billion by 2033 growing at a CAGR of 16.9% from 2025 to 2033.

The gene editing market has experienced transformative growth in recent years, driven by groundbreaking advancements in molecular biology, biotechnology, and genomics. Gene editing refers to the process of making precise alterations to an organism’s DNA, enabling the targeted modification of genetic material to treat diseases, enhance agricultural productivity, and create genetically modified organisms (GMOs). The market for gene editing technologies, especially CRISPR-Cas9, TALENs, and ZFNs, has expanded dramatically due to their ability to offer significant advantages over traditional genetic modification methods, such as faster results, higher accuracy, and lower costs. As a result, the gene editing market has witnessed wide applications in medicine, agriculture, and industrial biotechnology, with the potential to revolutionize various fields by offering solutions to genetic disorders, improving food security, and advancing personalized medicine.

Gene Editing Market Segmentation

The worldwide market for gene editing is split based on technology, product & services, application, end-user, and geography.

Gene Editing Market By Technology

CRISPR
TALEN
ZFN
Other Technologies

Gene Editing Market By Product & Services

Reagents & Consumables
Software & Systems
Services

Gene Editing Application

Cell Line Editing
Animal Genome Editing
Plant Genome Editing
Other

Gene Editing End-user

Pharmaceutical & Biotechnology Companies
Academics And Government Research Institutes
Clinical Research Organizations (CRO)

Gene Editing Market Regional Outlook

North America

U.S.

Canada

Europe

U.K.
Germany
France
Spain

Rest of Europe

Asia-Pacific

India
Japan
China
Australia
South Korea

Rest of Asia-Pacific

Latin America

Brazil
Mexico

Rest of LATAM

The Middle East & Africa

South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)

Gene Editing Market Players

Some of the top gene editing companies offered in our report include Sangamo Biosciences, Addgene, Thermo Fisher Scientific, Horizon Discovery Group plc, Allele Biotech, Bio-Rad, Caribou Biosciences, Inc., Precision Biosciences, CRISPR Therapeutics, GE Healthcare, GeneCopoeia, Inc., Integrated DNA Technologies, GenScript Corporation, and OriGene Technologies.

Table of Contents

250 Pages
CHAPTER 1 Industry Overview of Gene Editing Market
1.1 Definition and Scope
1.2 Summary
CHAPTER 2 Research Approach
2.1 Methodology
2.2 Data Source
CHAPTER 3 Market Dynamics And Competition Analysis
3.1 Market Drivers
3.2 Restraints and Challenges
3.3 Growth Opportunities
3.4 Porter’s Five Forces Analysis
3.5 Market Concentration Ratio and Market Maturity Analysis of Gene Editing Market
3.5.1 Go To Market Strategy
3.5.1.1 Introduction
3.5.1.2 Growth
3.5.1.3 Maturity
3.5.1.4 Saturation
3.5.1.5 Possible Development
3.6 Technological Roadmap for Gene Editing Market
3.7 Value Chain Analysis
3.7.1 List of Key Manufacturers
3.7.2 List of Customers
3.7.3 Level of Integration
3.8 Cost Structure Analysis
3.8.1 Price Trend of Key Raw Materials
3.8.2 Raw Material Suppliers
3.8.3 Proportion of Manufacturing Cost Structure
3.8.3.1 Raw Material
3.8.3.2 Labor Cost
3.8.3.3 Manufacturing Expense
3.9 Regulatory Compliance
3.10 Competitive Landscape, 2024
3.10.1 Player Positioning Analysis
3.10.2 Key Strategies Adopted By Leading Players
CHAPTER 4 Manufacturing Plant Analysis
4.1 Manufacturing Plant Location and Establish Date of Major Manufacturers in 2024
4.2 R&D Status of Major Manufacturers in 2024
CHAPTER 5 Gene Editing Market By Technology
5.1 Introduction
5.2 Gene Editing Revenue By Technology
5.2.1 Gene Editing Revenue (USD Billion) and Forecast, By Technology, 2021-2033
5.2.2 CRISPR
5.2.2.1 CRISPR Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
5.2.3 TALEN
5.2.3.1 TALEN Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
5.2.4 ZFN
5.2.4.1 ZFN Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
5.2.5 Other Technologies
5.2.5.1 Other Technologies Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 6 Gene Editing Market By Product & Services
6.1 Introduction
6.2 Gene Editing Revenue By Product & Services
6.2.1 Gene Editing Revenue (USD Billion) and Forecast, By Product & Services, 2021-2033
6.2.2 Reagents & Consumables
6.2.2.1 Reagents & Consumables Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
6.2.3 Software & Systems
6.2.3.1 Software & Systems Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
6.2.4 Services
6.2.4.1 Services Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 7 Gene Editing Market By Application
7.1 Introduction
7.2 Gene Editing Revenue By Application
7.2.1 Gene Editing Revenue (USD Billion) and Forecast, By Application, 2021-2033
7.2.2 Cell Line Editing
7.2.2.1 Cell Line Editing Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
7.2.3 Animal Genome Editing
7.2.3.1 Animal Genome Editing Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
7.2.4 Plant Genome Editing
7.2.4.1 Plant Genome Editing Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
7.2.5 Other
7.2.5.1 Other Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 8 Gene Editing Market By End-user
8.1 Introduction
8.2 Gene Editing Revenue By End-user
8.2.1 Gene Editing Revenue (USD Billion) and Forecast, By End-user, 2021-2033
8.2.2 Pharmaceutical & Biotechnology Companies
8.2.2.1 Pharmaceutical & Biotechnology Companies Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
8.2.3 Academics And Government Research Institutes
8.2.3.1 Academics And Government Research Institutes Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
8.2.4 Clinical Research Organizations (CRO)
8.2.4.1 Clinical Research Organizations (CRO) Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 9 North America Gene Editing Market By Country
9.1 North America Gene Editing Market Overview
9.2 U.S.
9.2.1 U.S. Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
9.2.2 U.S. Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
9.2.3 U.S. Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
9.2.4 U.S. Gene Editing Revenue (USD Billion) and Forecast By End-Use, 2021-2033
9.3 Canada
9.3.1 Canada Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
9.3.2 Canada Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
9.3.3 Canada Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
9.3.4 Canada Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
9.4 North America PEST Analysis
CHAPTER 10 Europe Gene Editing Market By Country
10.1 Europe Gene Editing Market Overview
10.2 U.K.
10.2.1 U.K. Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
10.2.2 U.K. Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
10.2.3 U.K. Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
10.2.4 U.K. Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
10.3 Germany
10.3.1 Germany Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
10.3.2 Germany Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
10.3.3 Germany Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
10.3.4 Germany Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
10.4 France
10.4.1 France Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
10.4.2 France Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
10.4.3 France Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
10.4.4 France Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
10.5 Spain
10.5.1 Spain Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
10.5.2 Spain Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
10.5.3 Spain Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
10.5.4 Spain Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
10.6 Rest of Europe
10.6.1 Rest of Europe Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
10.6.2 Rest of Europe Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
10.6.3 Rest of Europe Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
10.6.4 Rest of Europe Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
10.7 Europe PEST Analysis
CHAPTER 11 Asia Pacific Gene Editing Market By Country
11.1 Asia Pacific Gene Editing Market Overview
11.2 China
11.2.1 China Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
11.2.2 China Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
11.2.3 China Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
11.2.4 China Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.3 Japan
11.3.1 Japan Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
11.3.2 Japan Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
11.3.3 Japan Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
11.3.4 Japan Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.4 India
11.4.1 India Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
11.4.2 India Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
11.4.3 India Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
11.4.4 India Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.5 Australia
11.5.1 Australia Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
11.5.2 Australia Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
11.5.3 Australia Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
11.5.4 Australia Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.6 South Korea
11.6.1 South Korea Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
11.6.2 South Korea Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
11.6.3 South Korea Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
11.6.4 South Korea Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.7 Rest of Asia-Pacific
11.7.1 Rest of Asia-Pacific Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
11.7.2 Rest of Asia-Pacific Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
11.7.3 Rest of Asia-Pacific Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
11.7.4 Rest of Asia-Pacific Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
11.8 Asia Pacific PEST Analysis
CHAPTER 12 Latin America Gene Editing Market By Country
12.1 Latin America Gene Editing Market Overview
12.2 Brazil
12.2.1 Brazil Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
12.2.2 Brazil Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
12.2.3 Brazil Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
12.2.4 Brazil Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
12.3 Mexico
12.3.1 Mexico Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
12.3.2 Mexico Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
12.3.3 Mexico Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
12.3.4 Mexico Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
12.4 Rest of Latin America
12.4.1 Rest of Latin America Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
12.4.2 Rest of Latin America Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
12.4.3 Rest of Latin America Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
12.4.4 Rest of Latin America Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
12.5 Latin America PEST Analysis
CHAPTER 13 Middle East & Africa Gene Editing Market By Country
13.1 Middle East & Africa Gene Editing Market Overview
13.2 GCC
13.2.1 GCC Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
13.2.2 GCC Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
13.2.3 Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
13.2.4 Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
13.3 South Africa
13.3.1 South Africa Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
13.3.2 South Africa Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
13.3.3 South Africa Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
13.3.4 South Africa Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
13.4 Rest of Middle East & Africa
13.4.1 Rest of Middle East & Africa Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033
13.4.2 Rest of Middle East & Africa Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033
13.4.3. Rest of Middle East & Africa Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033
13.4.4 Rest of Middle East & Africa Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033
13.5 Middle East & Africa PEST Analysis
CHAPTER 14 Player Analysis Of Gene Editing Market
14.1 Gene Editing Market Company Share Analysis
14.2 Competition Matrix
14.2.1 Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2 New Product Launches and Product Enhancements
14.2.3 Mergers And Acquisition In Global Gene Editing Market
14.2.4 Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15 Company Profile
15.1 Sangamo Biosciences
15.1.1 Company Snapshot
15.1.2 Business Overview
15.1.3 Financial Overview
15.1.3.1 Revenue (USD Billion), 2024
15.1.3.2 Sangamo Biosciences 2024 Gene Editing Business Regional Distribution
15.1.4 Product /Service and Specification
15.1.5 Recent Developments & Business Strategy
15.2 Addgene
15.3 Thermo Fisher Scientific
15.4 Horizon Discovery Group plc
15.5 Allele Biotech
15.6 Bio-Rad
15.7 Caribou Biosciences, Inc.
15.8 Precision Biosciences
15.9 CRISPR Therapeutics
15.10 GE Healthcare
15.11 GeneCopoeia, Inc
15.12 Integrated DNA Technologies
15.13 GenScript Corporation
15.14 OriGene Technologies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us